Fingerprint
Dive into the research topics of 'HER2 activating mutations are targets for colorectal cancer treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
HER2 activating mutations are targets for colorectal cancer treatment
Shyam M. Kavuri, Naveen Jain, Francesco Galimi, Francesca Cottino, Simonetta M. Leto, Giorgia Migliardi, Adam C. Searleman, Wei Shen, John Monsey, Livio Trusolino, Samuel A. Jacobs, Andrea Bertotti, Ron Bose
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Molecular Oncology & Developmental Therapeutics
- DBBS - Molecular Cell Biology
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
244
Scopus
citations